# A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems

> **NCT05718843** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 36 (actual)

## Conditions studied

- Renal Insufficiency

## Interventions

- **DRUG:** BI 425809

## Key facts

- **NCT ID:** NCT05718843
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-01
- **Primary completion:** 2023-10-24
- **Final completion:** 2023-10-24
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05718843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05718843, "A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05718843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*